Covagen AG Alternatives & Competitors
12 companies similar to Covagen AG — Crafting next-generation therapies through innovative protein and antibody fusio...
Companies similar to Covagen AG
Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious...
Canada
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, United States
Cellestia Biotech
Cellestia develops targeted therapies for cancer patients with no other options, including...
Basel, Switzerland
Rival Readout
Competing with Covagen AG? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Umea, Sweden
Harmonic Discovery
Embedding the complexity of disease into the drug discovery process
New York, United States
Denmark
Applied Molecular Transport
We are committed to developing transformational biologic medicines to serve patients with...
South San Francisco, Unit...
Alder Biopharmaceuticals
Dedicated to alleviating human suffering with safer and better antibody therapeutics throu...
Bright Biologics
Developing bispecific antibody drug to improve cancer treatment.
Sunnyvale, United States
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
About Covagen AG
Covagen AG is a biopharmaceutical company with a specialized focus on crafting next-generation therapies through innovative protein and antibody fusion for enhanced treatment of inflammatory diseases and cancer. The company's unique approach involves creating bispecific FynomAbs by merging its human Fynomer binding pro...
Drug Development, Therapeutics, FynomAbs, Protein Fusion, Antibody Fusion, Inflammatory Diseases, Cancer Treatment, Biological Pathways, Research Partnership, Spin-off Company, Investors, ETH Zurich, Novel Modes Of Action, Strategic Collaboration
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Covagen AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Covagen AG on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
